JENNIFER ANDERSON: Open Payments
NPI 1528114550 · DORCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 18 payments from 9 companies in 2025. Trend: 2023 $165 · 2024 $253 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $127 |
| Lilly USA, LLC | 3 | $76 |
| PFIZER INC. | 3 | $53 |
| Exact Sciences Corporation | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Chiesi USA, Inc. | 1 | $19 |
| Edwards Lifesciences Corporation | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: Kerendia, JARDIANCE, PAXLOVID, The Cologuard Plus Collection Kit, CAPLYTA, JASCAYD, JUXTAPID, Jornay PM.
Industry payments across MA — which companies pay providers there.
